This Article Full Text (OnlineFirst PDF) All Versions of this Article: 0003319707304582v1 59/2/198    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Qadan, L. R. Articles by Ali, A. A. Search for Related Content PubMed PubMed Citation Articles by Qadan, L. R. Articles by Ali, A. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Metabolic Syndrome Peripheral Arterial Disease Hazardous Substances DB TESTOSTERONE Social Bookmarking                         What's this?

Prevalence of Metabolic Syndrome in Patients With Clinically Advanced Peripheral Vascular Disease

Kuwait University

^* To whom correspondence should be addressed. E-mail: lailaqadan{at}hotmail.com.

	Abstract

The aim of this cross-sectional study was to determine the prevalence of metabolic syndrome (MetS) and its components among 100 patients with progressive peripheral arterial disease (PAD) referred for diagnostic angiography in preparation for a revascularization procedure. The prevalence of MetS was more than 95%. Diabetes mellitus was the most prevalent component followed by hypertension and low high-density lipoprotein. Almost half the patients aggregated in the highest metabolic score category. A direct relationship was identified between the number of MetS components and serum uric acid (P = .001) and C-reactive protein (P = .826), whereas an inverse relationship was seen between the clustering of components and androgen levels in men (P < .001). For PAD, which could have a benign clinical course, early screening for MetS might identify those at greater risk of failing conservative therapy and progressing to a more aggressive atherosclerotic disease typically associated with high morbidity and mortality.

First published on April 2, 2008, doi:10.1177/0003319707304582

Angiology 2008;59:198.

A more recent version of this article appeared on May 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Maksimovic, H. Vlajinac, D. Radak, J. Marinkovic, and J. Jorga Relationship Between Peripheral Arterial Disease and Metabolic Syndrome Angiology, October 1, 2009; 60(5): 546 - 553. [Abstract] [PDF]